SNOA News and Press, Sonoma Pharmaceuticals Inc. From 05/03/22

Gainers: Sonoma Pharmaceuticals (SNOA) +29%. Blue Water Vaccines (BWV) +32%. XORTX Therapeutics (XRTX) +27%. Eqonex  (EQOS) +21%. TETRA Technologies (TTI) +20%. Enovix (ENVX) +18%. JAKKS Pacific (JAKK) +18%. Blue Apron Holdings (APRN) +17%. Borr Drilling (BORR) +16%. Western Digital Corp...

Gainers: Sonoma Pharmaceuticals (SNOA) +42%. XORTX Therapeutics (XRTX) +18%. Retractable Technologies (RVP) +14%. Catalent (CTLT) +12%. Field Trip Health (FTRP) +5%. Losers: Spero Therapeutics (SPRO) -61%. Semler Scientific (SMLR) -23%. Galmed Pharmaceu...

What to Know About Buying Penny Stocks on May 3rd, 2022 After an interesting start to May for penny stocks and blue chips, there is a lot for investors to know right now. While morning gainers like Forte Biosciences Inc. ( NASDAQ: FBRX ) and SoundHound AI Inc. ( NASDAQ: SOUN ) a...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as we prepare for a busy day of trading on Tuesday! Source: oneinchpunch/Shutterstock.com Approval from the EPA and FCC, earnings reports, a...

Sonoma Pharmaceuticals (NASDAQ:SNOA) and its partner MicroSafe Group DMCC said they received U.S. Environmental Protection Agency (EPA) approval for Nanocyn as a hospital-grade disinfectant in the U.S. Nanocyn, which is manufactured by Sonoma using its patented Microcyn technology, is a ...

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions a...

Gainers: Adagio Therapeutics (ADGI) +48%. Vyant Bio (VYNT) +23%. Vir Biotechnology (VIR) +19%. Sonoma Pharmaceuticals (SNOA) +15%. Syros Pharmaceuticals (SYRS) +15%. Losers: Revelation Biosciences (REVB) -40%. UpHealth (UPH) -29%. The Valens (VLNS)...

Sonoma Pharma (NASDAQ:SNOA) is trading ~22% higher after it launched its urinary tract infection catheter and bladder rinse product in New Zealand, Australia and South Africa. The product, Microdox, is a non-irritating and non-toxic solution a...

Adagio Therapeutics (ADGI) +64% as COVID drug ADG20 meets main goals in trial; EUA filing in Q2. Vyant Bio (VYNT) +29% on FY results. Sonoma Pharmaceuticals (SNOA) +24% launches new urinary tract infection product through distributors in New Zealand, Australia and Sou...

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, and dermatological conditio...